Denied claims are not random. They follow patterns — and in ophthalmology, those patterns are highly predictable. The same five denial reasons account for the majority of rejected claims in eye care practices across the country, and each one has a defined prevention protocol.

The financial stakes are real. According to HFMA, reworking a denied claim costs providers an average of $25 per claim, with complex appeals reaching $117. At an average denial rate of 7%–12% for physician practices — per HFMA’s 2024 denial trend data — a mid-size ophthalmology practice can easily absorb $150,000–$300,000 in denial-related costs annually — a mix of direct rework expense and revenue that is never recovered.

This guide breaks down the five most prevalent denial reasons in ophthalmology billing, explains why each occurs in an eye care context specifically, and provides actionable steps your billing team can implement today — for broader context on how your practice’s denial rate compares to top-performer benchmarks in the Ophthalmology RCM Benchmarks Report 2026.

The payer rejects the claim because the clinical documentation does not establish that the service rendered was medically necessary under the payer’s coverage criteria. This is the most common denial reason across ophthalmology and one of the most expensive to recover.

Ophthalmology operates at the intersection of medical and vision care — a distinction that payers, particularly Medicare and Medicaid, monitor closely. Services like refraction, low vision aids, and routine eye exams are explicitly excluded from Medicare Part B coverage. If a claim for a medical eye evaluation does not clearly document the medical diagnosis driving the encounter — rather than routine vision maintenance — it will be denied.

Beyond the medical-versus-vision distinction, medical necessity denials also arise from documentation that does not meet payer-specific criteria for high-cost procedures. As the AAO’s guidance on documentation deficiencies in diagnostic testing notes, Medicare Administrative Contractors continue to identify lack of physician order and clinical documentation to support medical necessity as a primary source of errors. Anti-VEGF injections for wet AMD, for example, require specific documentation of diagnosis code (H35.31x), visual acuity benchmarks, and prior treatment history that vary by payer.

The claim is denied because a modifier was omitted, incorrectly applied, or created a combination inconsistent with the payer’s billing guidelines. Modifier errors are disproportionately common in ophthalmology because the specialty relies heavily on modifiers to distinguish bilateral procedures, separate services rendered on the same day, and identify global versus technical/professional component billing.

According to AAO Coding Experts, modifier usage — particularly for intravitreal injections, premium lens services, and bilateral procedures — is among the most frequent sources of billing errors. Modifier 25 (significant, separately identifiable evaluation and management service) is among the most audited modifiers in ophthalmology. When a patient presents for a cataract pre-op consultation and the physician performs an unrelated medical eye evaluation in the same visit, modifier 25 must be correctly applied to separate the E/M from the procedure.

Modifier 50 (bilateral procedure) and modifier RT/LT (right/left) are essential in ophthalmology for bilateral cataract procedures, bilateral injections, and diagnostic imaging. Modifier 59 (distinct procedural service) is frequently required when multiple eye procedures are performed during the same encounter. The TC/26 split (technical component/professional component) applies when diagnostic testing and interpretation are billed by different entities.

Optivate’s integrated billing platform includes built-in ophthalmology-specific claim scrubbing and modifier validation. Talk to our team about how it works.

The claim is denied because the service required prior authorization and either no authorization was obtained, the authorization was for a different service or date, or the authorization expired before the service was rendered.

Prior authorization requirements in ophthalmology are extensive and payer-specific. Procedures that routinely require prior authorization include: anti-VEGF injections (bevacizumab, ranibizumab, aflibercept, faricimab), laser procedures (PDT, SLT, ALT, PRP), surgical interventions (vitrectomy, trabeculectomy), and high-cost diagnostic imaging in certain commercial plans.

Authorization requirements change frequently. A commercial payer may add or remove a procedure from its authorization list mid-year with limited notice. Practices managing authorizations through manual spreadsheets or staff memory — rather than integrated authorization tracking — are particularly vulnerable to these gaps.

The claim is denied because the patient was not covered by the plan on the date of service, the service was not covered under their specific plan, coordination of benefits was not handled correctly, or a secondary payer was unknown at the time of billing.

Eligibility errors are particularly common in ophthalmology because many patients have both medical insurance (Medicare, commercial) and separate vision insurance (VSP, EyeMed, Spectera). The billing distinction between medical and vision claims — based on diagnosis and procedure type — must align with which insurance plan is being billed.

Patients do not always know their current coverage status. Medicare patients who have joined a Medicare Advantage plan may present with their original Medicare card. Commercial patients with mid-year employer benefit changes may not be aware that their plan, network status, or deductible has changed. Without real-time verification at or near the point of service, these errors reach the claim stage.

The claim is denied because the CPT code used does not match the service documented, the diagnosis code is not linked correctly to the procedure billed, or the procedure code combination violates payer bundling edits.

Ophthalmology has a large and granular CPT code set. The distinction between 92004 (comprehensive ophthalmological service, new patient) and 99203 (office visit, new patient, moderate complexity) is not always intuitive — and payers adjudicate it differently. As AAO Coding Experts have noted, determining whether to bill E/M codes (992xx) or eye visit codes (920xx) is among the most frequent sources of confusion and error for ophthalmologists, particularly those early in their careers.

CMS Correct Coding Initiative (CCI) edits define procedure code combinations that Medicare and many commercial payers consider inherently bundled. Billing a component code alongside a comprehensive code for the same encounter — without appropriate modifier justification — triggers automatic denial. Ophthalmology has a high density of CCI edit pairs relative to other specialties, given the multi-procedure nature of many encounters.

Optivate’s RCM team includes certified ophthalmology coders who audit your claims before submission. Request a conversation to learn more.

Most ophthalmology practices have a denial response process — staff who work denied claims, call payers, and submit appeals. Far fewer have a denial prevention system — one that uses denial data to identify and eliminate the root causes of preventable denials before claims are submitted.

The distinction matters financially. HFMA’s Claim Integrity Task Force states that organizations with denial rates below 3% share one common trait: they treat denial prevention as a clinical and administrative priority, not just a billing department responsibility. A reactive denial management process recovers some of what was denied but cannot recover the rework cost, the time delay, or the claims that are written off because appeal deadlines pass.

Building a prevention system requires three components: data (tracking denials by reason code, payer, provider, and procedure at a granular level), process (structured root-cause review and cross-functional accountability), and technology (integrated claim scrubbing, eligibility verification, and coding validation built into the submission workflow). If you are evaluating whether your current billing setup has the infrastructure to support a prevention-oriented RCM model, a full cost comparison of in-house vs. outsourced billing for ophthalmology practices is a useful starting point.

What is the most common reason ophthalmology claims are denied?

Medical necessity documentation failures are consistently the most common denial reason in ophthalmology. The specialty’s position at the intersection of medical and vision care — with Medicare’s explicit exclusion of routine vision services — makes documentation precision especially important for every encounter.

How do modifier errors cause claim denials in ophthalmology?

Ophthalmology relies heavily on modifiers 25, 50, 59, RT/LT, and TC/26 to correctly distinguish services performed in the same encounter or on bilateral structures. Omitted or incorrectly applied modifiers trigger automatic denial from most payers’ edit systems. A modifier matrix and pre-submission scrubbing are the primary preventive tools.

How can ophthalmology practices reduce prior authorization denials?

A live authorization matrix by payer, integrated into the scheduling workflow, eliminates the most common authorization gaps. Authorization tracking should include expiration dates, particularly for chronic disease management procedures like anti-VEGF injections administered on recurring schedules.

What are CCI edits and how do they affect ophthalmology billing?

CCI (Correct Coding Initiative) edits are CMS-maintained rules defining procedure code combinations considered inherently bundled. Billing both codes in a bundled pair without modifier justification triggers automatic denial. Ophthalmology has a high density of CCI edit pairs due to its multi-procedure encounter patterns.